Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1999-09-02
2000-09-05
Krass, Frederick
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514102, 514103, 514104, 514107, 514152, 514154, A61K 3166, A61K 3165
Patent
active
061143162
ABSTRACT:
Tissue-destructive conditions related to excess protemase activity in a biological system are treated or prevented by administering to the system a composition which combines a tetracycline and a bisphosphonate in synergistic proteinase inhibiting amounts.
REFERENCES:
patent: Re34656 (1994-07-01), Goulb et al.
patent: 4666897 (1987-05-01), Golub et al.
patent: 4704383 (1987-11-01), McNamara et al.
patent: 4935412 (1990-06-01), McNamara et al.
patent: 5258371 (1993-11-01), Golub et al.
patent: 5308839 (1994-05-01), Golub et al.
patent: 5321017 (1994-06-01), Golub et al.
patent: 5403829 (1995-04-01), Lehitinan et al.
patent: 5442101 (1995-08-01), Hanhijarvi et al.
patent: 5459135 (1995-10-01), Golub et al.
patent: 5652227 (1997-07-01), Pekka et al.
patent: 5668120 (1997-09-01), Shinoda et al.
patent: 5773430 (1998-06-01), Simon et al.
patent: 5880111 (1999-03-01), Farcasiu et al.
Ryan, M.E. et al., "Potential of Tetracycline to Modify Cartilage Breakdown in Osteoarthritis ", Curr. Opin. Rheumatology,8 (1996) 238-247.
Llano, E. et al., "Identification and Structural and Functional Characterization of Human Enamelysin (MMP-20), " Biochemistry,36 (1997) 15101-15108.
Salo, T. et al., "Enamelysin (MMP-20) is Expressed in Oral Squamous Cell Carcinoma Cells", J. Dent. Res., 77 (1998) 829 Abstract No. 1978.
Birkedal-Hansen, H., "Proteclytic Remodeling of Extracellular Matrix", Curr. Opin. Cell Biol.,7 (1995) 728-735.
Woessner Jr., J. F., "Matrix Metalloproteinases and their Inhibitors in Connective Tissue Remodeling", FASEB J., 5 (1991) 2145-2154.
Chandler, S. et al., "Matrix Metalloproteinases, Tumor Necrosis Factor and Multiple Sclerosis: An Overview", J. Neuroimmunology,72 (1997) 155-161.
van Hujsduijnen, R.H., "ADAM 20 and 21 ; Two Novel Human Testis-Specific membrance Metalloproteases with Similarity to Fertilin-.alpha.", Gene,206 (1998) 273-282.
Huovila, A.J. et al., "ADAMs and Cell Fusion", Curr. Opin. Cell. Biol.,8 (1996) 692-699.
Yagami-Hiromasa T. et al., "A Metalloprotease-Disintegrin Participating in Myoblast Fusion", Nature, 377 (1995) 652-656.
Perry, A.C. et al., Abstract: "Genetic Evidence for an Additional Member of the Metalloprotease-Like, Disintegrin-Like Cysteine-Rich (MDC) Family of mammalian Proteins and its Abundant Expression in the Testis", Biochem. Biophys, Acta(1994) 1207, 134-137.
Wolfsberg, T.G. et al., "ADAM, A Widely Distributed and developmentally Regulated Gene Family Encoding Membrance Proteins with a Disintegrin and Metalloprotease Domain", Developmental Biology,169 (1995) 378-383.
Watanabe, N. et al., "Processing and Release of Tumor Necrosis Factor .alpha.", Eur. J. Biochem.,253 (1998) 576-582.
Shapira, L. et al., "Tetracycline Inhbitors Porphyromonas Gingivalis Lipopolysaccharide-Induced Lesions in vivo and TNF.alpha.Processing in vitro," J. Period. Res., 32 (1997) 183-188.
Sorsa, L. et al., "Idenification of Proteases from Periodontopathogenic Bacteria as Activators of Latent Human Neutrophil and Fibroblast Type Interstital Collagenases", Infect. Immun.,60 (1992) 4491-4495.
Sorsa, T. et al., "Activation of Type IV Procollagenase by Human Tumor Asociated Trypsin 2, " J. Biol. Chem.,272 (1997) 21067-21074.
Lowe, F.C. et al., Abstract: "Biochemical Methods for Predicting Metastatic Ability of Prostatic Cancer Utilizing the Dunning R-3327 Rat Prostatic Adenocarcinoma System As A Model ", Cancer Res.,44 (1984) 744-752.
Stetler-Stevenson, W.G. et al., "Tumor Cell Interactions with the Extracelluar Matrix During Invasion and Matastasis", Annu. Rev. Cell Biol.,9 (1993) 541-573.
Tryggvason, K. et al., "Proteolytic Degradation of Extracellular Matrix in Tumor Invasion", Biochimica et Biophysica Acta,907 (1987), 191-217.
Grenwald, R.A. et al., "In Vivo Sensitivity of the Three Mammalian Collagenases to Tetracycline Inhibition: Relationship to Bone and Cartilage Degradation", Bone,22 (1998) 33-38.
Bourguignon, L. et al., "CD-44V3-Cytoskeleton Interaction and Matrix Metalloproteinase (MMP-9) Association Promote Lymphocyte Infiltration into Pancreatic Islets in NOD Mice", Mol. Biol. Cell,8i Suppl (1997), Abstract No. 1603.
Liedtke, W. et al., "Effective Treatment of Models of Multiple Sclerosis by Matrix Metalloproteinase Inhibitors", Annals of neurology, 44 (1998) 35-46.
Li, H. et al., "Immunological Characterization of Cell-Syrface and Soluble Forms of Membrance Type 1 Matrix Metalloproteinase in Human Breast Cancer Cells and in Fibroblasts", Mol. Carcinogensis,22 (1998) 84-94, Abstr..
Mallya, S.K. et al., "Intetaction of Matrix Metalloproteinase with Serine Protease Inhibitors", Ann. NY Acad. Sci.,732 (1994) 303-314.
Zernicke, R.F. et al., "Administration of System Matrix Metalloproteinase Inhibitors Maintains Bone Mechanical Integrity in Adjuvant Arthritis", J. Rheumatology,24 (1997) 1324-1331.
Sorsa, T. et al., "Functional Sites of Chemically Modified Tetracyclines: Inhibition of the Oxidative Activation of Human Neutrophil and Chicken Osteroclast ProMatrix Metalloptoteinase", J. Rheumatology,25 (1998) 975-982.
Golub, L.M. et al., "Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non Antimicrobial Mechanisms", Adv. Dental Research, (1998) in press.
Mitscher L.A., The Chemistry of the tetracycline Antibiotics,Marcel Dekker, New York (1978), ch. 6, 165-218.
Giannelli, G. et al. "Induction of Cell Migration by Matrix Metalloproteinase-2 Cleavage of Laminin-5", Science, 277 (1997) 225-8.
Fleisch, H., "Biophosphonates: Mechanisms of Action", Endocrine Reviews,19 (1998) 80.
Ramamurthy, N.S. et al., "The Effects of Alloxan Diabetics on Prolyl and Lysyl Hydroxylase Activity in Uminflamed and Inflamed Rat Gingiva", Archs. oral Biol.,30 (1985) 679-683.
Hanahan, D. et al., "Pattern and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis", Cell86 (1996) 353-364.
Teronen, O. et al., "Human Neutrophil Collagenase MMP-8 In Peri-Implant Sulcus Fluid and its Inhibition by Clondronate", J. Dental Res.,76 (1997) 1529-1537.
Sorsa, T. et al., "Effects of Tetracycline on Neutrophil, Gingival, and Salivary Collagenase", Ann. NY Acad. Sci.,732 (1994) 112-131.
Golub, L.M. et al., "A Matrix Metalloproteinase Inhibitor Reduces Bone-Type Collagen Degration Fragments and Specific Collagenases in Gingival Crevicular Fluid During Adult Periodontitis", Inflamm. Res.,46 (1997) 310-319.
Golub Lorne M.
Ramamurthy Nungavarm S.
Salo Tuula A.
Sorsa Timo A.
Teronen Olli P.
Krass Frederick
Research Foundation of S.U.N.Y.
LandOfFree
Combination of bisphosphonate and tetracycline does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination of bisphosphonate and tetracycline, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of bisphosphonate and tetracycline will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2212267